Literature DB >> 15001126

Biliary atresia.

Hiroyuki Kobayashi1, Mark D Stringer.   

Abstract

Biliary atresia (BA) is a congenital obliterative cholangiopathy of unknown aetiology, affecting both the intra- and extrahepatic bile ducts. Although relatively rare, BA must be excluded in any infant with conjugated hyperbilirubinaemia since the prognosis is improved by early diagnosis and prompt surgery. At least two phenotypes of BA are currently recognized; the syndromic variety is associated with other congenital anomalies and a poorer outcome. The results of treatment have steadily improved and, with a combination of timely expert surgery (Kasai portoenterostomy) and liver transplantation in specialist centres, good quality long-term survival is now possible in more than 90% of affected patients. A better understanding of the aetiology of BA and the pathogenesis of hepatic fibrosis is needed in order to develop new therapeutic strategies.

Entities:  

Mesh:

Year:  2003        PMID: 15001126     DOI: 10.1016/S1084-2756(03)00065-4

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  11 in total

1.  Association of circulating osteopontin levels with clinical outcomes in postoperative biliary atresia.

Authors:  Sittisak Honsawek; Paisarn Vejchapipat; Voranush Chongsrisawat; Nutchanart Thawornsuk; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2010-11-03       Impact factor: 1.827

2.  The correlation between plasma cytokine levels in jaundice-free children with biliary atresia.

Authors:  Zhi-Hong Jian; Li-Ching Wang; Chieh-Chung Lin; Jiaan-Der Wang
Journal:  World J Pediatr       Date:  2015-04-06       Impact factor: 2.764

3.  There is no association between K469E ICAM-1 gene polymorphism and biliary atresia.

Authors:  Paisarn Vejchapipat; Naruemol Jirapanakorn; Nutchanart Thawornsuk; Apiradee Theamboonlers; Voranush Chongsrisawat; Soottiporn Chittmittrapap; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

4.  Elevated serum nitric oxide metabolites in biliary atresia.

Authors:  Paisarn Vejchapipat; Voranush Chongsrisawat; Apiradee Theamboonlers; Soottiporn Chittmittrapap; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

5.  Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia.

Authors:  Sittisak Honsawek; Tawatchai Chaiwatanarat; Paisarn Vejchapipat; Voranush Chongsrisawat; Nutchanart Thawornsuk; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2009-01-29       Impact factor: 1.827

Review 6.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

Review 7.  Liver transplantation for biliary atresia: a systematic review.

Authors:  Mureo Kasahara; Koji Umeshita; Seisuke Sakamoto; Akinari Fukuda; Hiroyuki Furukawa; Shinji Uemoto
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

8.  The usefulness of immunohistochemical staining of bile tracts in biliary atresia.

Authors:  Joanna Cielecka-Kuszyk; Maria Janowska; Małgorzata Markiewicz; Piotr Czubkowski; Anna Ostoja-Chyżyńska; Joanna Beata Bierła; Bożena Cukrowska; Joanna Pawłowska
Journal:  Clin Exp Hepatol       Date:  2021-03-25

9.  Biliary atresia: 50 years after the first kasai.

Authors:  Barbara E Wildhaber
Journal:  ISRN Surg       Date:  2012-12-06

10.  Two Rare Cases of Hepatocellular Carcinoma after Kasai Procedure for Biliary Atresia: A Recommendation for Close Follow-Up.

Authors:  Alicia C Hirzel; Beatrice Madrazo; Claudia P Rojas
Journal:  Case Rep Pathol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.